ARWR EBITDA Margin
Arrowhead Pharmaceuticals Inc · EBITDA Margin
ARWR EBITDA Margin
Latest reported-19.97%period ending
ARWR EBITDA Margin (-71.59% → -19.97%)
Annual ebitda margin
High-resolution chart · PNG
ARWR ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 19.8713% | |
| -15,812.8133% | |
| -72.9732% | |
| -66.7218% | |
| -95.8724% | |
| -99.1192% | |
| 38.8813% | |
| -317.4076% | |
| -102.8584% | |
| -48,272.8578% | |
| -24,512.505% | |
| -28,433.2823% | |
| -7,417.2714% | |
| -13,167.8203% | |
| -3,228.9864% | |
| 105.5785% | |
| -494.0041% | |
| -2,598.9237% | |
| -3,058.3304% | |
| -3,290.9837% | |
| -1,514.9991% | |
| -1,332.6607% | |
| 0% | |
| -62,097.7935% | |
| -1,103.2968% | |
| -408.4452% | |
| -129.9962% | |
| -25.0273% | |
| -71.5929% |